Ophiomics is a start up developing precision medicine solutions for liver cancer. We marry artificial intelligence with genomics and molecular biology to develop the next generations of in vitro diagnostics medical devices, associated with decisions algorithms. As our first products approaches market-readiness, Ophiomics wishes to identify a Technical Writer to work in house, full-time, for
It is with great joy that we announce that Prof. Christophe Duvoux joined Ophiomics’ advisory board. (From the ILTS site:) Christophe Duvoux is full Professor of Hepatology and Transplant Hepatogist. He is head of the Medical Liver Transplantation Program at Henri Mondor Hospital-Paris Est University. He has been chairing ELITA (European Liver & Intestine Transplantation
Ophiomics secures €1M in Seed Round as part of an EIC accelerator award. Funding round will support regulatory compliance and clinical validation Lisbon, June 9th, 2021 – Ophiomics, a R&D biotechnology and AI company based in Lisbon, Portugal, today announced it raised seed capital of 1M€ from the EIC Fund complementing the EIC Accelerator Grant previously
Ophiomics was short listed as one of the top 25 scale ups in Portugal 2020! Thank you BGI for your efforts in putting together the Scale Up Report every year and for the recognition of our work From their site: “Scaleup Portugal was born in 2017, after BGI was asked who were the best Portuguese startups by
Great News! Ophiomics just won the Everis Award – Portugal, and is now in the final stage of the competition to the International Everis Award in November. The Everis Award Portugal, in addition to the always so important monetary component, includes coaching by experts from the Everis network. Thank you Everis Foundation. You can read the
Health Europa, a publisher of digital content on Health issue sin Europe and beyond, published a feature about Ophiomics and HepatoPredict in its Health Europa Quarterly Issue.